Apyx Medical: Business Model, SWOT Analysis, and Competitors 2026

Apyx Medical Corporation stands as a leading company in Healthcare. Generating $47.90 million in annual revenue (growing 12.1% year-over-year) and carrying a market capitalization of $133.76 million, the company has cemented its position as a foundational player in the global Medical Devices landscape. Under the leadership of its leadership team, Apyx Medical Corporation continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Apyx Medical Corporation's business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Apyx Medical Corporation as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Apyx Medical Corporation's position in the Medical Devices market today.

What You Will Learn

1. How Apyx Medical Corporation generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Apyx Medical Corporation's competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Apyx Medical Corporation's main competitors are and how the company compares on key financial metrics
4. Apyx Medical Corporation's key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Apyx Medical Corporation's strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $47.90 million annual revenue (TTM), +12.1% YoY
• Market Cap: $133.76 million — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 62.6%, operating margin -6.5%, net margin -30.4%
• Free Cash Flow: $-5.91 million
• Return on Equity: -168.1% — reflects current investment phase
• Employees: 220 worldwide

Who Owns Apyx Medical Corporation?

Apyx Medical Corporation is publicly traded on the NASDAQ under the ticker symbol APYX. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Apyx Medical Corporation are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Apyx Medical Corporation has approximately 41 million shares outstanding, with float shares of 0 million — the freely tradeable portion. The stock trades at $3.26 per share as of early 2026.

Apyx Medical Corporation's Mission Statement

Apyx Medical Corporation's strategic mission is aligned with its core business activities in the Medical Devices sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Apyx Medical Corporation's most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Apyx Medical Corporation, the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Apyx Medical Corporation's strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Apyx Medical Corporation Make Money?

As of 2026, Apyx Medical Corporation generates $47.90 million in annual revenue (growing 12.1% year-over-year), with a 62.6% gross margin and -6.5% operating margin. Market capitalization stands at $133.76 million. Here is how the company generates its revenue:

As of 2026, Apyx Medical Corporation generates $47.90 million in annual revenue (growing 12.1% year-over-year), with a 62.6% gross margin and -6.5% operating margin. Market capitalization stands at $133.76 million. Here is how the company generates its revenue:

Revenue Streams

Apyx Medical Corp generates revenue through various channels, ensuring a diversified income stream. The company primarily makes money through the sales of its innovative and high-quality medical devices and related accessories. These products are designed to enhance precision, efficiency, and safety in surgical procedures, attracting a wide customer base in the healthcare industry.

Electrosurgical Generator Systems

One of the primary revenue streams for Apyx Medical Corp is the sale of electrosurgical generator systems. These systems enable healthcare professionals to perform various surgical procedures with greater accuracy and control. The generators provide the necessary electrical energy to precisely cut, coagulate, and ablate tissue during surgeries, resulting in improved patient outcomes. Apyx Medical Corp offers a range of electrosurgical generators tailored to specific surgical specialties, such as cosmetic surgery, dermatology, and gynecology.

Consumable Products

In addition to electrosurgical generators, Apyx Medical Corp also generates revenue through the sale of consumable products. These products include disposable electrodes, blades, and other accessories that are essential for the proper functioning of the electrosurgical generators. As these consumables need to be replaced regularly, they create a recurring revenue stream for the company.

Service and Maintenance Contracts

Apyx Medical Corp further supplements its revenue by offering service and maintenance contracts to its customers. These contracts provide ongoing support and regular maintenance for the electrosurgical generator systems, ensuring their optimal performance. By offering these contracts, the company not only generates additional income but also enhances customer satisfaction and loyalty.

Licensing and Royalties

Apyx Medical Corp also generates revenue through licensing agreements and royalties. The company holds a portfolio of patents and intellectual property rights related to its innovative medical devices. By licensing these technologies to other medical device manufacturers, Apyx Medical Corp receives royalties based on the sales of products incorporating its patent

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review Apyx Medical Corporation's latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

Apyx Medical Corporation Business Model Canvas

The Business Model Canvas framework provides a structured view of how Apyx Medical Corporation creates, delivers, and captures value.

Key Partners: Apyx Medical Corporation's key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Medical Devices sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Apyx Medical Corporation's most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Apyx Medical Corporation's critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (220 employees), proprietary technology, and financial resources ($25.14M in cash).

Value Propositions: Apyx Medical Corporation delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Medical Devices market.

Customer Relationships: Apyx Medical Corporation maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Apyx Medical Corporation reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Apyx Medical Corporation serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Apyx Medical Corporation's major costs include cost of goods sold (37.4% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 106.5% of revenue.

Revenue Streams: Apyx Medical Corporation generates revenue through its core product and service offerings.

Apyx Medical Corporation Competitors

Apyx Medical Corporation competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Medical Devices segment of the Healthcare sector.

Apyx Medical Corporation SWOT Analysis

A SWOT analysis examines Apyx Medical Corporation's internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: Apyx Medical Corporation's gross margin of 62.6% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of -6.5% demonstrates disciplined cost management even at scale.
• Revenue Growth: Revenue grew 12.1% year-over-year to $47.90M, indicating strong demand for Apyx Medical Corporation's products and services and outperformance relative to many industry peers.

Weaknesses

• High Financial Leverage: With a debt-to-equity ratio of 644.9, Apyx Medical Corporation carries significant debt relative to equity. While manageable given its cash flow, elevated leverage limits financial flexibility and increases vulnerability to rising interest rates.

Opportunities

• Total Addressable Market: Apyx Medical Corporation operates in the Medical Devices segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Apyx Medical Corporation's products and services.
• Strategic Acquisitions: With $25.14M in cash and strong free cash flow generation, Apyx Medical Corporation is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Apyx Medical Corporation's revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Apyx Medical Corporation's business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Apyx Medical Corporation enters 2026 as a leading company in Healthcare, backed by $47.90 million in annual revenue and a -30.4% net profit margin. The company's 62.6% gross margins and $-5.91 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Apyx Medical Corporation's core markets.

For investors and analysts, Apyx Medical Corporation represents an important company to understand within the Healthcare sector. Key metrics to track include revenue growth, margin trends, and competitive positioning updates.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – Apyx Medical, SEC EDGAR – Apyx Medical Filings, and Apyx Medical's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. What does Apyx Medical Corporation do?

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers

2. How much revenue does Apyx Medical Corporation make?

Apyx Medical Corporation generated $47.90 million in annual revenue (TTM), with 12.1% year-over-year growth.

3. What is Apyx Medical Corporation's market cap?

Apyx Medical Corporation's market capitalization is approximately $133.76 million as of early 2026.

4. Is Apyx Medical Corporation profitable?

Apyx Medical Corporation has faced profitability challenges recently. Investors should review the latest quarterly earnings reports.

5. Who are Apyx Medical Corporation's competitors?

Apyx Medical Corporation competes in the Medical Devices sector against companies including Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE).

6. Does Apyx Medical Corporation pay dividends?

Apyx Medical Corporation does not currently pay a dividend, choosing to reinvest earnings into growth initiatives.

7. What is Apyx Medical Corporation's stock ticker?

Apyx Medical Corporation trades on the NASDAQ under the ticker symbol APYX.

8. What is Apyx Medical Corporation's P/E ratio?

Valuation multiples for Apyx Medical Corporation can be found on major financial platforms such as Yahoo Finance, Bloomberg Terminal, or the company's latest annual report filing.

9. How many employees does Apyx Medical Corporation have?

Apyx Medical Corporation employs approximately 220 people worldwide as of the most recent disclosure.

10. What is Apyx Medical Corporation's competitive advantage?

Apyx Medical Corporation's competitive advantages include its established brand, scale in Medical Devices, and track record of execution in the Healthcare sector.